The drug delivery industry experienced tremendous growth over the past decade due to patent expirations on many blockbuster pharmaceutical products and the spectacular growth in the biotechnology industry.

As a response to their patent expiry crisis, large pharmaceutical companies initiated product life cycle management (LCM) strategies in order to decrease the loss of market share.

One LCM strategy involves the use of drug delivery to either improve a product's performance, provide for product line extensions, or to decrease the cost of goods.

In addition, many pharmaceutical companies evaluate drug delivery technologies for applicability to molecules in their pipelines. For these reasons drug delivery technologies will play a key role in the growth of the pharmaceutical industry over the years to come. The advantages of using drug delivery systems to formulate a new product include: extending the market exclusivity, increasing hurdles for duplicating pharmacokinetic profiles, increasing patent protection and providing a product line extension.

ALRISE Biosystems GmbH
Robert-Roessle-Straße 10
Otto-Warburg-Haus
13125 Berlin, Germany
Phone +49 30.94 89 24 83
Fax +49 30.94 89 24 82
info@alrise.de